Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1951 1
1952 3
1953 5
1955 1
1956 2
1957 1
1958 1
1959 2
1960 1
1965 1
1970 1
1971 1
1973 1
1975 1
1982 1
1988 1
1989 6
1990 5
1991 3
1992 3
1993 1
1994 2
1995 2
1998 1
2000 1
2001 3
2002 4
2003 3
2004 2
2005 4
2006 4
2007 5
2008 2
2009 2
2010 4
2011 8
2012 9
2013 8
2014 6
2015 7
2016 6
2017 12
2018 13
2019 20
2020 23
2021 33
2022 33
2023 44
2024 27
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

299 results

Results by year

Filters applied: . Clear all
Page 1
Liquorice Toxicity: A Comprehensive Narrative Review.
Ceccuzzi G, Rapino A, Perna B, Costanzini A, Farinelli A, Fiorica I, Marziani B, Cianci A, Rossin F, Cesaro AE, Spampinato MD, De Giorgio R, Guarino M. Ceccuzzi G, et al. Among authors: cesaro ae. Nutrients. 2023 Sep 5;15(18):3866. doi: 10.3390/nu15183866. Nutrients. 2023. PMID: 37764649 Free PMC article. Review.
Antibiotic failure: Beyond antimicrobial resistance.
de la Fuente-Nunez C, Cesaro A, Hancock REW. de la Fuente-Nunez C, et al. Among authors: cesaro a. Drug Resist Updat. 2023 Nov;71:101012. doi: 10.1016/j.drup.2023.101012. Epub 2023 Oct 18. Drug Resist Updat. 2023. PMID: 37924726 Review.
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry.
Paolisso P, Bergamaschi L, Santulli G, Gallinoro E, Cesaro A, Gragnano F, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Casella G, Mauro C, Vassilev D, Marfella R, Calabrò P, Barbato E, Pizzi C. Paolisso P, et al. Among authors: cesaro a. Cardiovasc Diabetol. 2022 May 15;21(1):77. doi: 10.1186/s12933-022-01506-8. Cardiovasc Diabetol. 2022. PMID: 35570280 Free PMC article.
Andrographolide, a Natural Antioxidant: An Update.
Mussard E, Cesaro A, Lespessailles E, Legrain B, Berteina-Raboin S, Toumi H. Mussard E, et al. Among authors: cesaro a. Antioxidants (Basel). 2019 Nov 20;8(12):571. doi: 10.3390/antiox8120571. Antioxidants (Basel). 2019. PMID: 31756965 Free PMC article. Review.
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR.
Van Mieghem NM, Unverdorben M, Hengstenberg C, Möllmann H, Mehran R, López-Otero D, Nombela-Franco L, Moreno R, Nordbeck P, Thiele H, Lang I, Zamorano JL, Shawl F, Yamamoto M, Watanabe Y, Hayashida K, Hambrecht R, Meincke F, Vranckx P, Jin J, Boersma E, Rodés-Cabau J, Ohlmann P, Capranzano P, Kim HS, Pilgrim T, Anderson R, Baber U, Duggal A, Laeis P, Lanz H, Chen C, Valgimigli M, Veltkamp R, Saito S, Dangas GD; ENVISAGE-TAVI AF Investigators. Van Mieghem NM, et al. N Engl J Med. 2021 Dec 2;385(23):2150-2160. doi: 10.1056/NEJMoa2111016. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449183 Clinical Trial.
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque.
Marfella R, Prattichizzo F, Sardu C, Paolisso P, D'Onofrio N, Scisciola L, La Grotta R, Frigé C, Ferraraccio F, Panarese I, Fanelli M, Modugno P, Calafiore AM, Melchionna M, Sasso FC, Furbatto F, D'Andrea D, Siniscalchi M, Mauro C, Cesaro A, Calabrò P, Santulli G, Balestrieri ML, Barbato E, Ceriello A, Paolisso G. Marfella R, et al. Among authors: cesaro a. Atherosclerosis. 2023 Aug;378:117180. doi: 10.1016/j.atherosclerosis.2023.06.971. Epub 2023 Jun 29. Atherosclerosis. 2023. PMID: 37422356
Visceral adipose tissue and residual cardiovascular risk: a pathological link and new therapeutic options.
Cesaro A, De Michele G, Fimiani F, Acerbo V, Scherillo G, Signore G, Rotolo FP, Scialla F, Raucci G, Panico D, Gragnano F, Moscarella E, Scudiero O, Mennitti C, Calabrò P. Cesaro A, et al. Front Cardiovasc Med. 2023 Jul 27;10:1187735. doi: 10.3389/fcvm.2023.1187735. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37576108 Free PMC article. Review.
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes.
Marfella R, Prattichizzo F, Sardu C, Rambaldi PF, Fumagalli C, Marfella LV, La Grotta R, Frigé C, Pellegrini V, D'Andrea D, Cesaro A, Calabrò P, Pizzi C, Antonicelli R, Ceriello A, Mauro C, Paolisso G. Marfella R, et al. Among authors: cesaro a. Cardiovasc Diabetol. 2024 Jan 6;23(1):10. doi: 10.1186/s12933-023-02118-6. Cardiovasc Diabetol. 2024. PMID: 38184582 Free PMC article.
299 results